Ilan Hadar
Chairman and CEO, Director · Silexion Therapeutics Corp
Individual
- 2026
- Jun 8, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ilan Hadar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mitchell Shirvan - $31K in SLXN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ilan Hadar?
Ilan Hadar is a corporate insider, tracked as Chairman and CEO, Director of Silexion Therapeutics Corp (SLXN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Ilan Hadar last file a Form 4?
The most recent primary Form 4 on record is dated 8 June 2026, one of 2 filings going back to 2026.
